Therakind Ltd

New legislation from the European Parliament will make it compulsory to investigate any new drug that may be used in children by performing appropriate paediatric clinical studies. This will entail all pharmaceutical companies researching new and specially designed paediatric drug formulations that will be acceptable to children. Therakind’s collaboration with the Centre for Paediatric Pharmacy Research at the School of Pharmacy, University of London, provides the company with the unique capacity to fulfil this legislation on behalf of client pharmaceutical companies. This includes the provision of appropriate study design, approval and management and the ability to generate more acceptable drug formulations and drug delivery modalities for children.

Year founded

2006

therakind.com